Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Cardizem (Diltiazem) Drips: The ICU Nurse's Guide

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Pharmacology Hub — browse every related guide in one place.

When a patient hits the unit in atrial fibrillation with a rapid ventricular response, the diltiazem drip is often the first tool out of the box for rate control. It works well and titrates smoothly — but there are specific patients in whom it is exactly the wrong drug. Here is the practical picture.

The short version: Diltiazem (Cardizem) is a non-dihydropyridine calcium channel blocker used to slow the ventricular rate in atrial fibrillation or flutter with rapid ventricular response (RVR), and in some SVTs. Typical dosing is a weight-based bolus (~0.25 mg/kg over 2 min, repeatable at ~0.35 mg/kg), followed by an infusion of ~5–15 mg/hr. The main risks are hypotension and bradycardia. Avoid it in decompensated heart failure, WPW with AFib, and undifferentiated wide-complex tachycardia.

How diltiazem works

Diltiazem blocks calcium channels in cardiac tissue, slowing conduction through the AV node and reducing heart rate. Unlike the dihydropyridine calcium blockers (like nicardipine) that act mainly on blood vessels, diltiazem's dominant effect is on the heart's electrical conduction and contractility. In AFib with RVR, slowing AV conduction reduces how many atrial impulses reach the ventricles, bringing the rate down and improving filling and cardiac output. It has some vasodilatory effect too, which is why blood pressure can fall.

Dosing

StepTypical dose
Initial bolus~0.25 mg/kg IV over 2 min
Second bolus (if needed)~0.35 mg/kg IV over 2 min after ~15 min
Continuous infusion~5–15 mg/hr, titrated to rate
GoalVentricular rate control (often < 110 bpm) per order
Bedside rule of thumb: Push the bolus slowly and watch the pressure — the rate usually breaks within minutes. Then titrate the infusion to a rate target, not to zero symptoms. Rate control, not conversion to sinus, is the goal of the diltiazem drip; the rhythm may stay in AFib.

Side effects to monitor

Hypotension. The most common concern, from the bolus especially. In a patient whose rapid rate is compensating for something (sepsis, hypovolemia), lowering it can drop the pressure — assess volume and cause before assuming rate is the whole problem.

Bradycardia and AV block. Its whole mechanism is slowing the AV node, so excessive slowing, heart block, and pauses are possible — especially combined with other AV nodal agents like beta-blockers, digoxin, or amiodarone.

Worsening heart failure. Diltiazem is a negative inotrope — it reduces contractility.

The patients to avoid

Three situations where diltiazem can harm. First, decompensated systolic heart failure / reduced EF — its negative inotropy can worsen the failure; it is relatively contraindicated in significant LV dysfunction. Second, WPW (pre-excitation) with atrial fibrillation — blocking the AV node can shunt conduction down the accessory pathway and precipitate ventricular fibrillation; these patients need different management. Third, undifferentiated wide-complex tachycardia — if the rhythm is actually VT, an AV nodal blocker can be catastrophic. When in doubt about a wide-complex rhythm, do not reach for diltiazem.

Diltiazem vs the alternatives for AFib rate control

AgentNote
DiltiazemFast, effective; avoid in low EF and WPW
Beta-blockers (metoprolol)Alternative; also caution in decompensated HF
AmiodaroneOption when HF or hypotension limit CCB/BB
DigoxinSlower onset; useful adjunct in HF

Why CRNA students should know it

On the CRNA path, new-onset perioperative atrial fibrillation is common, and rate-control drugs like diltiazem are part of managing it. Understanding its AV-nodal mechanism, its hemodynamic effects, and the heart-failure and WPW cautions at the ICU bedside is exactly the reasoning you will use intraoperatively.

Bottom line

The diltiazem drip is the go-to for AFib with RVR: weight-based bolus, then a titrated infusion to a rate target. Respect the hypotension and bradycardia, remember it is a negative inotrope, and steer clear of it in decompensated heart failure, WPW with AFib, and wide-complex tachycardia. Learn it now and it carries into anesthesia practice.

Related pharmacology: pair with the amiodarone guide for rhythm/rate control and the vasopressor guide for managing any resulting hypotension.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.